Xeris Pharmaceuticals Inc SC 13G and SC 13G/A reports

Location
180 North Lasalle Street, Suite 1600, Chicago, IL
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/30/2024, 05:09 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Feb 14, 2022
SC 13G Report Jul 12, 2021
SC 13G Report Mar 17, 2021
SC 13G/A Report Feb 16, 2021
SC 13G/A Report SC 13G/A Feb 16, 2021
SC 13G/A Report SCHEDULE 13G HOLDINGS REPORT AMENDMENT Feb 16, 2021
SC 13G/A Report Feb 12, 2021
SC 13G/A Report XERIS PHARMACEUTICALS, INC. Feb 11, 2021
SC 13G/A Report Feb 1, 2021
SC 13G Report Jul 10, 2020
SC 13G/A Report SC 13G/A Mar 10, 2020
SC 13G Report Feb 21, 2020
SC 13G Report SCHEDULE 13G HOLDINGS REPORT Feb 14, 2020
SC 13G/A Report SCHEDULE 13G/A Feb 14, 2020
SC 13G/A Report Feb 13, 2020
SC 13G Report SC 13G Feb 7, 2020
SC 13G Report Feb 7, 2020
SC 13G/A Report Jan 10, 2020
SC 13G/A Report Nov 8, 2019
SC 13G/A Report Feb 13, 2019
SC 13G/A Report Feb 12, 2019
SC 13G Report Nov 13, 2018
SC 13G Report Jun 27, 2018
SC 13G Report SC 13G Jun 27, 2018